about
When drug discovery meets web search: Learning to Rank for ligand-based virtual screeningProteochemometric modeling of the bioactivity spectra of HIV-1 protease inhibitors by introducing protein-ligand interaction fingerprintProteochemometric modeling of the antigen-antibody interaction: new fingerprints for antigen, antibody and epitope-paratope interactionScreening of selective histone deacetylase inhibitors by proteochemometric modeling.In silico target-specific siRNA design based on domain transfer in heterogeneous data.iPEAP: integrating multiple omics and genetic data for pathway enrichment analysis.Gene expression module-based chemical function similarity search.SEPPA 2.0--more refined server to predict spatial epitope considering species of immune host and subcellular localization of protein antigen.Discrimination of approved drugs from experimental drugs by learning methodsQuantitatively integrating molecular structure and bioactivity profile evidence into drug-target relationship analysisInvestigations on inhibitors of hedgehog signal pathway: a quantitative structure-activity relationship studyIntegrating clinical indexes into four-diagnostic information contributes to the Traditional Chinese Medicine (TCM) syndrome diagnosis of chronic hepatitis B.Functional Cross-Talking between Differentially Expressed and Alternatively Spliced Genes in Human Liver Cancer Cells Treated with Berberine.Screening Ingredients from Herbs against Pregnane X Receptor in the Study of Inductive Herb-Drug Interactions: Combining Pharmacophore and Docking-Based Rank Aggregation.Combining genomic and network characteristics for extended capability in predicting synergistic drugs for cancer.Comparison of different ranking methods in protein-ligand binding site prediction.Predicting the Mutating Distribution at Antigenic Sites of the Influenza Virus.Identification of Toxic Pyrrolizidine Alkaloids and Their Common Hepatotoxicity Mechanism.HIM-herbal ingredients in-vivo metabolism databaseTowards a bioinformatics analysis of anti-Alzheimer's herbal medicines from a target network perspective.The recent progress in proteochemometric modelling: focusing on target descriptors, cross-term descriptors and application scope.Binding Mechanism of Inhibitors to CDK5/p25 Complex: Free Energy Calculation and Ranking Aggregation Analysis.Insight into potential toxicity mechanisms of melamine: an in silico study.Study on human GPCR-inhibitor interactions by proteochemometric modeling.The response of archaeal species to seasonal variables in a subtropical aerated soil: insight into the low abundant methanogens.HuoXueJieDu Formula Alleviates Diabetic Retinopathy in Rats by Inhibiting SOCS3-STAT3 and TIMP1-A2M Pathways.A review of Chinese herbal medicine for the treatment of chronic heart failure.Differential analysis of chromatin accessibility and histone modifications for predicting mouse developmental enhancers3D-QSAR studies with the aid of molecular docking for a series of non-steroidal FXR agonistsDecomposing the Mechanism of Qishen Granules in the Treatment of Heart Failure by a Quantitative Pathway Analysis MethodAntiapoptosis and Antifibrosis Effects of Qishen Granules on Heart Failure Rats via Hippo Pathway
P50
Q27902275-C0E5C672-21A9-45A8-8D68-A92624EBF297Q28481635-E17F8596-4AEE-4D9B-8C8F-A76187E3D7A1Q28546634-C4882C3B-27F7-43E5-80D8-872B7C193626Q30420578-CAAEFBCC-D20A-46A9-9AD9-FBA2FB06FEEEQ30584270-FEB1F2B0-43B1-4F4D-8C2F-1108AB913644Q30671343-728DF1E0-302E-418D-A3FB-CDAB0B271317Q33374699-F8A10B4A-59FB-42D9-87E1-D06327BBD79BQ33860688-992217EC-3CE4-4864-8D35-766603D0E0D4Q33899201-0DB08DC2-9214-4BC4-8A5C-FA6B8D9E090FQ34258626-184BD5FD-1338-421D-B061-B2537C5EA20BQ35048554-959145D9-BAEE-4431-8730-5428768BCFDBQ35206285-A2626632-4DBA-45D8-832E-5B483FD3EA49Q35852321-6BB979D3-8930-4204-BD53-767ADCE7BADFQ35960314-20CDD19A-8396-4780-ABD5-8E5FEA268514Q36139333-73D48C08-E9FC-4909-89F6-5BCC47D1134DQ36197297-34AAD59E-66C7-4B89-8368-452CA16FDCC3Q36536284-4C95656F-12B7-4933-BA08-A3E27A61A902Q36743564-A1D8B9FE-CBFC-4DCB-9D4B-5DE7B0422A78Q36921811-C86E014E-5CDB-457B-B1BE-8AD9BBC84233Q38034180-B7C75C0D-390D-42E8-86C4-C4616FA2FDE1Q38731960-2A923021-47B3-443E-A716-60726EAD7996Q39460467-8DD4394A-25C5-4534-90C6-0456EE94E07FQ42747370-FBC07F7A-D2A0-4A72-912C-490CCB94B2FFQ44489111-D571B461-4EA5-4192-9689-17BD135CFCAEQ46359327-DDC4F3C7-A7FB-4E48-8572-0EAE61614F89Q48275105-CDBAC1DE-256A-446A-8AEC-6659E6CB98B8Q49817469-EC0D2017-3DF1-46CD-B6ED-D54E5EC15590Q57991435-AFCBBD2A-90A0-43CD-913F-C3D10CD6BFEEQ79792137-414526A3-5860-431C-AF63-689063402781Q90446645-2C3E6CC3-4575-45C9-B7ED-165430945F29Q92505528-3154B434-15DB-4C18-8D48-98D583DD1582
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Rui-Xin Zhu
@en
Rui-Xin Zhu
@nl
type
label
Rui-Xin Zhu
@en
Rui-Xin Zhu
@nl
prefLabel
Rui-Xin Zhu
@en
Rui-Xin Zhu
@nl
P2456
P31
P496
0000-0002-5070-6453